middle.news
Optiscan lodges FDA dossier for InSpecta and advances clinical trials for US market push
9:38am on Thursday 30th of April, 2026 AEST
•
Healthcare
Read Story
Optiscan lodges FDA dossier for InSpecta and advances clinical trials for US market push
9:38am on Thursday 30th of April, 2026 AEST
Key Points
FDA dossier submitted for InSpecta® veterinary device
Clinical studies advancing for InVue® and InForm® devices
R&D spend of $1.67 million supports regulatory progress
Commercial launch preparations underway for US veterinary market
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Optiscan Imaging (ASX:OIL)
OPEN ARTICLE